LCID
Lucid Group, Inc.
LCID has the edge over RGS overall, supported by lower modeled downside and stronger modeled upside.
RGS
Regis Corporation
RGS trails on the overall score without a compensating advantage in the available component scores.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
RGS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Under pressure |
RGS's profitability and cash flow are currently stable, but its revenue and balance sheet are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
RGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $1.05 | -96% |
| Fair | 0.6x | $1.27 | -95% |
| Expensive | 0.7x | $1.39 | -94% |
| Current | 11x | $23.55 | — |
Historical ranges are pointers, not guarantees.
RGS's PE is in its expensive range at 11x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
RGS Forward outlook
There aren't enough analyst estimates for RGS to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
RGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | -96% |
| Q2 2026 | $2.41 | -95% |
| Q1 2026 | $44.58 | +9.4% |
| Q4 2025 | $44.40 | +12% |
| Q3 2025 | $46.95 | +26% |
| Q2 2025 | $46.10 | +20% |
| Q1 2025 | $40.74 | +$42.71 |
| Q4 2024 | $39.66 | +$41.43 |
RGS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over RGS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
RGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.3M | -7.8% |
| Q2 2026 | $56M | -7.3% |
| Q1 2026 | $52.4M | -8% |
| Q4 2025 | $57.1M | +22% |
| Q3 2025 | $59M | +28% |
| Q2 2025 | $60.4M | +22% |
| Q1 2025 | $57M | +16% |
| Q4 2024 | $46.7M | -8.5% |
RGS's revenue fell from its 2019 peak and has held roughly level since: $54M last quarter, down 7.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.8% | -0.3 points |
| Q2 2026 | 12% | -0.3 points |
| Q1 2026 | 11% | +2.1 points |
| Q4 2025 | 11% | -0.9 points |
| Q3 2025 | 10% | +5.4 points |
| Q2 2025 | 12% | +2.8 points |
| Q1 2025 | 8.8% | +0.5 points |
| Q4 2024 | 12% | +2.4 points |
RGS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
RGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.1M | +11% |
| Q2 2026 | $3.6M | -42% |
| Q1 2026 | $4.8M | -19% |
| Q4 2025 | $891K | -48% |
| Q3 2025 | $1.9M | +$3.2M |
| Q2 2025 | $6.2M | +23% |
| Q1 2025 | $5.9M | +$6.2M |
| Q4 2024 | $1.7M | +$5.9M |
RGS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
RGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +44K shares |
| 1 year | +5.1% | +142K shares |
| 3 years | +24% | +561K shares |
| 5 years | +59% | +1.1M shares |
| Available history | +63% | +1.1M shares |
RGS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $1,000 |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 4.1x | High |
| Q1 2025 | 4.8x | High |
| Q4 2024 | 5.2x | High |
RGS's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.3 | Neutral |
| Stochastic | 35.1 | Neutral |
RGS's weekly RSI is 36 (neutral) and its Stochastic is 35 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
RGS PE vs Consumer Cyclical Sector
| Metric | RGS | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 38% below |
| PE % | 92 | 47 | 45 pts above |
RGS is trading at 11x earnings, a 38% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
RGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.8 | 15% below |
| 20 week MA | $27.7 | 15% below |
| 50 week MA | $26.5 | 11% below |
| 100 week MA | $24.8 | 5% below |
| 200 week MA | $21.2 | 11% above |
RGS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
RGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $359.0 | $189.6 | -47% |
| 2021 | $189.6 | $33.8 | -82% |
| 2022 | $33.8 | $24.2 | -28% |
| 2023 | $24.2 | $9.45 | -61% |
| 2024 | $9.45 | $25.5 | +170% |
| 2025 | $25.5 | $27.4 | +7.4% |
| 2026 YTD | $27.4 | $23.6 | -14% |
RGS has the edge over LCID on returns for 2026, with the stronger performance.